---
figid: PMC11932845__fonc-14-1415820-g001
figtitle: FGF/FGFR signalling pathway in mammary epithelium and TNBC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11932845
filename: fonc-14-1415820-g001.jpg
figlink: /pmc/articles/PMC11932845/figure/F1/
number: F1
caption: Schematic representation of FGF/FGFR signalling pathway in mammary epithelium
  and TNBC. The FGFR family has a basic structure comprising of three contiguous immunoprotein-like
  structural domains (Ig I, Ig II, and Ig III) in the extracellular and transmembrane
  regions, as well as intracellular membrane tyrosine kinase structural domains;In
  normal mammary epithelium, FGFR regulates Wnts, BMPs, Grb7, and PTHrP to maintain
  normal mammary epithelial function and sustain mammary epithelial stem cell differentiation;In
  TNBC, hyperactivation of the FGFR leads to overactivation of the PLCγ-PKC, STAT,
  PI3K-AKT, and Ras pathways, which trigger a range of biological behaviours in tumour
  cells;Hyperactivation of FGFR can result from activating mutations, gene amplification,
  chromosomal translocations, and aberrant ligands;Inhibition of FGFR can be achieved
  through TKIs, FGFR mAbs, and FGF traps, whether selective or non-selective
papertitle: 'Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR'
reftext: Jinhao Chen, et al. Front Oncol. 2024;14(NA).
year: '2024'
doi: 10.3389/fonc.2024.1415820
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media SA
keywords: TNBC | FGF/FGFR pathway | tumor microenvironment | targeted therapies |
  FGFR inhibitor
automl_pathway: 0.9474137
figid_alias: PMC11932845__F1
figtype: Figure
redirect_from: /figures/PMC11932845__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11932845__fonc-14-1415820-g001.html
  '@type': Dataset
  description: Schematic representation of FGF/FGFR signalling pathway in mammary
    epithelium and TNBC. The FGFR family has a basic structure comprising of three
    contiguous immunoprotein-like structural domains (Ig I, Ig II, and Ig III) in
    the extracellular and transmembrane regions, as well as intracellular membrane
    tyrosine kinase structural domains;In normal mammary epithelium, FGFR regulates
    Wnts, BMPs, Grb7, and PTHrP to maintain normal mammary epithelial function and
    sustain mammary epithelial stem cell differentiation;In TNBC, hyperactivation
    of the FGFR leads to overactivation of the PLCγ-PKC, STAT, PI3K-AKT, and Ras pathways,
    which trigger a range of biological behaviours in tumour cells;Hyperactivation
    of FGFR can result from activating mutations, gene amplification, chromosomal
    translocations, and aberrant ligands;Inhibition of FGFR can be achieved through
    TKIs, FGFR mAbs, and FGF traps, whether selective or non-selective
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - IGL
  - BMS1P20
  - IGLL5
  - IGLL1
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - HSPG2
  - SDC2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - GRB7
  - PTHLH
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - KRAS
  - HRAS
  - NRAS
  - Ras
---
